The human polymeric immunoglobulin receptor (pIgR; also known as membrane secretory component) is a 100 kDa type I transmembrane glycoprotein that is synthesized as a 764 amino acid (aa) precursor. It includes a signal sequence (aa 1-18), an extracellular region (aa 19-638), a transmembrane segment (aa 639-661), and a cytoplasmic domain (aa 662-764) (1-3). The extracellular region consists of five Ig-like domains and a sixth non-Ig domain that connects to the membrane region. pIgR is expressed on secretory epithelial cells of exocrine tissues. Immunoglobulin isotypes consist of two heavy (H) and two light (L) chains. For IgA and IgM, this H2L2 monomer can form larger polymers through association with a joining chain (J chain). The Fc regions of IgA and IgM have a carboxy-terminal extension called a secretory tailpiece that binds the J chain (4). pIgR functions as a carrier that transports IgA and IgM across epithelium (5). On the basolateral surface of epithelial cells, the receptor initially binds non-covalently to IgA via a docking site on the J chain. This initiates a rearrangement in which a disulfide bond forms between pIgR and an IgA heavy chain (2). The complexes are then internalized and transcytosed to the apical surface. A soluble covalent complex called secretory IgA (SIgA) is now generated by proteolytic cleavage of the sixth extracellular domain of pIgR and released into the lumen (6). This IgA-bound and proteolytically generated pIgR fragment is referred to as secretory component (SC). Notably, human pIgR transcytoses constitutively, with or without ligand, creating both bound and free, 78 kDa SC following cleavage (3). The extracellular region of pIgR is 64%, 65% and 70% aa identical to the equivalent region in rat, mouse and porcine, respectively. The receptor component of the complex anchors the SIgA molecule to mucous (7). SIgA is a crucial component of the mucosal immune system serving to protect the large expanse of mucous membranes that form a barrier between the interior of the body and the external environment (8).
Recombinant Human pIgR Protein, CF
R&D Systems | Catalog # 2717-PG
Loading...
Key Product Details
- R&D Systems NS0-derived Recombinant Human pIgR Protein (2717-PG)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
NS0
Accession Number
Applications
Binding Activity
Loading...
Product Specifications
Source
Mouse myeloma cell line, NS0-derived human pIgR protein
Lys19-Arg638, with a C-terminal 6-His tag
Lys19-Arg638, with a C-terminal 6-His tag
Purity
>97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.01 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Lys19
Predicted Molecular Mass
68.7 kDa
SDS-PAGE
90-95 kDa, reducing conditions
Activity
Measured by its binding ability in a functional ELISA.
When Recombinant Human plgR is immobilized at 2 μg/mL (100 μL/well), the concentration of human IgM that produces 50% of the optimal binding response is found to be approximately 20-100 ng/mL.
When Recombinant Human plgR is immobilized at 2 μg/mL (100 μL/well), the concentration of human IgM that produces 50% of the optimal binding response is found to be approximately 20-100 ng/mL.
Formulation, Preparation, and Storage
2717-PG
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution | Reconstitute at 100 μg/mL in sterile PBS.
Loading...
|
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Calculators
Background: pIgR
References
- Krajci, P. et al. (1989) Biochem. Biophys. Res. Commun. 158:783.
- Piskurich, J. et al. (1995) J. Immunol. 154:1735.
- Brandtzaeg, P. and F-E. Johansen (2001) Trends Immunol. 22:545.
- Braathen, R. et al. (2002) J. Biol. Chem. 277:42755.
- Ben-Hur, H. et al. (2004) Int. J. Mol. Med. 14:35.
- Asano, M. et al. (2004) Immunology 112:583.
- Phalipon, A. and B. Corthesy (2003) Trends Immunol. 24:55.
- Uren, T. et al. (2003) J. Immunol. 170:2531.
Long Name
Polymeric Immunoglobulin Receptor
Alternate Names
FLJ22667, hepatocellular carcinoma associated protein TB6, Hepatocellular carcinoma-associated protein TB6, MGC125361, MGC125362, PIgR, Poly-Ig receptor, polymeric immunoglobulin receptor
Gene Symbol
PIGR
UniProt
Additional pIgR Products
Product Documents for Recombinant Human pIgR Protein, CF
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Recombinant Human pIgR Protein, CF
For research use only
Citations for Recombinant Human pIgR Protein, CF
Customer Reviews for Recombinant Human pIgR Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human pIgR Protein, CF and earn rewards!
Have you used Recombinant Human pIgR Protein, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review